NVNO
enVVeno Medical CorporationMarquee-fund ownership over time
This quarter's activity
New positions opened
None.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors | Q3 2024 | Q2 2026 | — | +0% |
| Two Sigma Investments | Q1 2026 | Q2 2026 | — | +0% |
| AQR Capital Management | Q4 2025 | Q2 2026 | — | +0% |
| Renaissance Technologies | Q3 2025 | Q2 2026 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at enVVeno Medical Corp. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Mar 13, 2026 — the most recent Form 4 on file — not from today.
- Form 40001493152-26-010047Mar 13, 2026
- Form 40001493152-25-028396Dec 18, 2025
- Form 40001493152-25-028394Dec 18, 2025
- Form 40001493152-25-028392Dec 18, 2025
- Form 40001493152-25-027848Dec 15, 2025
- Form 40001493152-25-027834Dec 15, 2025
- Form 40001493152-25-027832Dec 15, 2025
- Form 40001493152-25-027826Dec 15, 2025
- Form 40001493152-25-027510Dec 12, 2025
- Form 40001493152-25-013837Sep 17, 2025
- Form 40001641172-25-011744May 20, 2025
- Form 40001493152-25-000160Jan 3, 2025
- Form 40001493152-25-000058Jan 2, 2025
- Form 40001493152-24-052112Dec 26, 2024
- Form 40001493152-24-051172Dec 23, 2024
Fundamentals
XBRL · enVVeno Medical CorporationAnnual figures sourced directly from enVVeno Medical Corporation's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for enVVeno Medical Corp — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-QQuarterly reportMay 6, 2026
- 8-KMaterial eventApr 29, 2026
- 10-KAnnual reportMar 26, 2026
- 8-KMaterial eventFeb 4, 2026
- 8-KMaterial eventJan 20, 2026
- 8-KMaterial eventDec 12, 2025
- 8-KMaterial eventNov 20, 2025
- 8-KMaterial eventNov 14, 2025
- 8-KMaterial eventOct 30, 2025
- DEF 14AProxy statementOct 30, 2025
- 10-QQuarterly reportOct 30, 2025
- 8-KMaterial eventOct 10, 2025
- 8-KMaterial eventAug 20, 2025
- 10-QQuarterly reportJul 31, 2025
- 8-KMaterial eventMay 20, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Two Sigma Investments | Q1 2026 | Q2 2026 | $0.00 | — | +0% |
| AQR Capital Management | Q4 2025 | Q2 2026 | $0.00 | — | +0% |
| Renaissance Technologies | Q3 2025 | Q2 2026 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2024 | Q2 2026 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.